Widget by:Get Widget

Breaking: Biden proposes expanding coverage of anti-obesity medications such as Wegovy and Zepbound to millions through Medicare and Medicaid

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌  ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ 
Read in browser

Tue Nov 26 2024

 
 
FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. The Biden administration wants to expand coverage of these weight-loss drugs for millions of Medicare and Medicaid recipients. REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo
READ FULL STORY→

SUBSCRIBE TODAY

Our Reporting. Your Stories.

  Access subscriber-only content on all of your devices.
 
  Share a bonus subscription with a family member or friend.
 
  Read our universal eNewspaper - the digital version of our print paper.
 
  Experience bonus monthly magazines and hundreds of local papers.
SUBSCRIBE TODAY

Newsletters   |    eNewspaper   |    Crosswords

Follow Us

Problem viewing email? View in browser

LiveIntent Logo AdChoices Logo

Postingan terkait:

Belum ada tanggapan untuk "Breaking: Biden proposes expanding coverage of anti-obesity medications such as Wegovy and Zepbound to millions through Medicare and Medicaid"

Posting Komentar